Videos / Recombinant respiratory syncytial virus pre-fusion F protein vaccine
In this Product Explainer, Infectious Disease Physician and Microbiologist Prof Paul Griffin explains the role of a recombinant respiratory syncytial virus pre-fusion F protein vaccine for prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).
Additional resources
Autism Spectrum Disorder in Children
Early Menopause
Donanemab – A GP Guide to Anti-Amyloid Therapies
LDL and Cardiovascular Disease
expert
Infectious Diseases Physician and Clinical Microbiologist; Director of Infectious Diseases, Mater Hospital; Lecturer, University of Queensland